News

Discover-NOW making significant impact on health data research

The Discover-NOW team showcased their achievements over the last 18 months through a series of lightening talks from academia, healthcare and pharma.

On Wednesday 26 May, the Discover-NOW team showcased their achievements over the last 18 months through a series of lightening talks from academia, healthcare and pharma. Attendees were given unique insights into their nationally endorsed approach to Public Patient Involvement and Engagement, including insights from a citizen representative who has helped to steer their public deliberations. It was also an opportunity to learn about how to work with Discover-NOW as they revolutionise the way health data is used for research into treating and preventing disease.

Lightening case studies and talks featured:

Industry Partners
Collaboration of NWEH and Discover-NOW to provide a new feasibility service, Martin Gibson, CEO NWEH
Healthcare Transformation in Type 2 Diabetes in NWL: AstraZeneca, Ross Stone, Global Programme Director, Digital Healthcare

Healthcare Partner
Healthcare usage in bariatric surgery in people living with SMI and obesity – real world data, Samantha Scholtz – Consultant Psychiatrist, West London NHS Trust

Academic Partner
Diabetic Kidney Disease and multimorbidity – real world data, Professor Frederick Tam MBBChir FRCP PhD FHEA FASN, Imperial College

How has patient involvement made a difference to the workings of the Hub?
Amy Darlington, Executive Director, Imperial College Health Partners
Barrie Newton, Citizen representative